Seems to be yet again, it's the flippers that try to get everyone worked up like they did with the increase in shares. Trying to be the voice of everyone when the vote end up being a landslide.

All the posts about the compensation and few posts about the milestones. Do the whiners really know what a CEO makes, especially in SF? Instead of a per mo. breakdown, try per hour. Do you really think he's working 9-5?

Basically Amarantus is showing their cards. All those questions of what is happening when is now quite clear. This is the best news of the week and we got a lot of great news this week.

Stop trying to spin it into one more flip. If people were that worried, they would dump their shares on Monday. Be foolish to make a big deal of it before you dumped now wouldn't it. Unless they were trying to stir things up. Take your whining up with the company directly instead of posting 10 times here in a row about the same thing.


Milestone: Nasdaq uplist
Bonus Performance: 30%
Completion Timing: 12/31/14

Milestone: Eltoprazine US IND filed and approved for LID
Bonus Performance: 30%
Completion Timing: 12/31/14

Milestone: LymPro partner validation of analytical performance package (APP) and CLIA certification
Bonus Performance: 25%
Completion Timing: 12/31/14

Milestone: MANF Orphan drug designation applications filed and approved for both Ocular Ischemic Syndrome (OIA) and Retinitis Pigmentosa
Bonus Performance: 15%
Completion Timing: 12/31/14

Read More: http://investorshangout.com/post/view?id=2126...z3FnBILLlE